Author

Marina Nasrin Sharifi

University of Wisconsin–MadisonORCID 0000-0003-0128-3033Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Shuang George ZhaoiD· 2 shared Aishwarya SubramanianiD· 1 shared Alexandra Zigrossi· 1 shared Andrea Gallardo· 1 shared Andrew S. GoldsteiniD· 1 shared Angel RuiziD· 1 shared Austin P RundeiD· 1 shared Blake R. WildeiD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Shuang George ZhaoORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 28, 2025

OGDHL regulates tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer

Matthew J. Bernard, Angel Ruiz, Johnny A. Diaz…·Andrew S. Goldstein

This study identifies OGDHL as a regulator of tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer, with implications for treatment resistance.

DOI 10.1101/2025.05.28.656673

humanproteomics

𝕏 PostBluesky

Cancer BiologyBreast Cancer ResearchPeer-reviewedJan 17, 2025

Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S ESR1 Mutant Breast Cancer Cells

Kristen S. Young, Govinda R Hancock, Emma C. Fink…·Sean William Fanning

This study investigates how a novel SERM, T6I-29, downregulates DKK1 in Y537S ESR1 mutant breast cancer cells and identifies DKK1 as a potential therapeutic target.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 2, 2024

A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapy

Aishwarya Subramanian, Meng Zhang, Marina Nasrin Sharifi…·Martin Sjöström

This study identifies a gastrointestinal gene expression phenotype in metastatic castration-resistant prostate cancer that correlates with reduced response to androgen receptor inhibitors.

DOI 10.1101/2024.06.02.595931

humanbulk RNA-seq

𝕏 PostBluesky